New encapsulating technology for whole-cell vaccines stimulates enhanced immunogenicity against Escherichia coli in a mouse model, shaping the future of urinary tract infection (UTI) vaccines. Recurrent…
A second incidence of a HIV patient’s body eliminating intact HIV genomes without the aid of treatment has been discovered. …
A promising new tool uses CRISPR technology and, uniquely, the Cas13d enzyme to provide faster results than PCR tests for…
The largest real-world observational study of the third ‘booster’ dose of the mRNA COVID-19 vaccine demonstrates its effectiveness against severe SARS-CoV-2-related illness, hospitalization, and…
Scientists in Sweden have created a new class of non-antibiotic hydrogel capable of fighting multidrug-resistant (MDR) bacterial infections by enhancing…
Researchers collate hepatitis B virus (HBV) genomic data over the past 10 millennia, illuminating the ancestry of the virus and…
A historic moment: WHO recommends deployment of a malaria vaccine finally developed after a 100-year endeavour. The WHO have advised that the RTS,S/AS01 vaccine, also known as Mosquirix, developed by GlaxoSmithKline (London, England) over the last 30 years in…
Brazilian research groups collaborate to uncover a correlation between high levels of Gas6 protein and the neurological complications of Zika…
Researchers discover bacteriophage ‘Muddy’ and antibiotic rifabutin as a new dynamic duo combination therapy against antibiotic-resistant Mycobacterium abscessus infection in a cystic fibrosis zebrafish model. A group of researchers…
‘Controller’ patients naturally suppress HIV infection, but in some patients increased KLF2 expression and impaired T-cell function triggers T cells to abort…
